These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
875 related articles for article (PubMed ID: 18045772)
1. Editorial comment on: postchemotherapy retroperitoneal lymph node dissection in advanced germ cell cancer tumors of the testis. Culine S Eur Urol; 2008 Feb; 53(2):273-4. PubMed ID: 18045772 [No Abstract] [Full Text] [Related]
2. Editorial comment on: postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumors of the testis. Jacqmin D Eur Urol; 2008 Feb; 53(2):272-3. PubMed ID: 18045771 [No Abstract] [Full Text] [Related]
3. Postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumours of the testis. Heidenreich A; Thüer D; Polyakov S Eur Urol; 2008 Feb; 53(2):260-72. PubMed ID: 18045770 [TBL] [Abstract][Full Text] [Related]
4. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements. Rabbani F; Gleave ME; Coppin CM; Murray N; Sullivan LD Cancer; 1996 Aug; 78(3):480-6. PubMed ID: 8697394 [TBL] [Abstract][Full Text] [Related]
5. Role of postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumors. Nguyen CT; Stephenson AJ Hematol Oncol Clin North Am; 2011 Jun; 25(3):593-604, ix. PubMed ID: 21570611 [TBL] [Abstract][Full Text] [Related]
6. Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection. Djaladat H; Nichols C; Daneshmand S Ann Surg Oncol; 2012 Jul; 19(7):2388-93. PubMed ID: 22395993 [TBL] [Abstract][Full Text] [Related]
7. [Aortic replacement during post chemotherapy retroperitoneal residual tumor resection for nonseminomatous germ cell tumor: a case report]. Matsuzaki M; Nakano M; Komatsu H; Ohashi K Hinyokika Kiyo; 2005 Dec; 51(12):831-4. PubMed ID: 16440734 [TBL] [Abstract][Full Text] [Related]
8. [A case of synchronous cervical lymph node metastases from testicular and thyroid cancers showing mixed response to chemotherapy]. Matsumoto H; Nakane H; Aoki A; Naito K; Imate Y; Ohkami K; Isoyama R Hinyokika Kiyo; 2000 Jul; 46(7):505-8. PubMed ID: 10965461 [TBL] [Abstract][Full Text] [Related]
9. Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma. Carver BS; Shayegan B; Serio A; Motzer RJ; Bosl GJ; Sheinfeld J J Clin Oncol; 2007 Mar; 25(9):1033-7. PubMed ID: 17261854 [TBL] [Abstract][Full Text] [Related]
10. Clinical parameters that predict histology of postchemotherapy retroperitoneal lymph node mass in testicular cancer. Onozawa M; Kawai K; Yamamoto T; Hinotsu S; Tsukamoto S; Hattori K; Miyanaga N; Shimazui T; Akaza H Int J Urol; 2004 Jul; 11(7):535-41. PubMed ID: 15242364 [TBL] [Abstract][Full Text] [Related]
12. Retroperitoneal lymph node dissection (RPLND) post chemotherapy for non-seminomatous testicular neoplasms: what is the significance of residual masses at scanner control after chemotherapy and should they be removed? Solé-Balcells F; Villavicencio H; Germá R Prog Clin Biol Res; 1989; 303():759-62. PubMed ID: 2780671 [No Abstract] [Full Text] [Related]
13. Postchemotherapy retroperitoneal lymph node dissection is effective therapy in selected patients with elevated tumor markers after primary chemotherapy alone. Coogan CL; Foster RS; Rowland RG; Bihrle R; Smith ER; Einhorn LH; Roth BJ; Donohue JP Urology; 1997 Dec; 50(6):957-62. PubMed ID: 9426730 [TBL] [Abstract][Full Text] [Related]